Sairah Ahmed, MD, is a board-certified hematology and medical oncology physician and an Associate Professor in the division of Cancer Medicine at the University of Texas, MD Anderson Cancer Center.

Her primary position is in the Lymphoma/Myeloma department with a co-appointment in the Stem Cell Transplantation and Cellular Therapy department. Dr. Ahmed serves as Co-Chair of the Morbidity, Recovery and Survivorship Scientific Working Committee (focused on Cellular Therapy) as part of the Center for International Blood and Marrow Transplant Research (CIBMTR).  Dr Ahmed has authored or coauthored over 130 peer-reviewed journal articles and at least 5 book chapters. She is a member of the American Society of Clinical Oncology, American Society of Hematology, and the American Society of Blood and Marrow Transplantation (ASTCT). She is a 2022 graduate of the ASTCT Mid-Career Leadership Training Course.

Dr Ahmed’s area of clinical practice is in lymphoma, and her research interests and experience are in early phase clinical trials, and chimeric antigen receptor T (CART) cell therapy for the treatment Hodgkin lymphoma and B-cell non-Hodgkin lymphoma.  She is the Director of the CART program in Lymphoma/Myeloma department at MD Anderson Cancer Center.